Dr. Lal PathLabs (NSE:LALPATHLAB) Total Stockholders Equity : ₹18,493 Mil (As of Mar. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Dr. Lal PathLabs Total Stockholders Equity?

Dr. Lal PathLabs's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ₹18,493 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Dr. Lal PathLabs's Book Value per Share for the quarter that ended in Mar. 2024 was ₹222.23. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Dr. Lal PathLabs's Debt-to-Equity for the quarter that ended in Mar. 2024 was 0.13.

Dr. Lal PathLabs Total Stockholders Equity Historical Data

The historical data trend for Dr. Lal PathLabs's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dr. Lal PathLabs Total Stockholders Equity Chart

Dr. Lal PathLabs Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Total Stockholders Equity

Get a 7-Day Free Trial

10,328.08

12,450.59

15,080.77

16,662.98

18,492.83

Dr. Lal PathLabs Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Stockholders Equity	Get a 7-Day Free Trial															16,662.98	-	17,722.00	-	18,492.83

Dr. Lal PathLabs (NSE:LALPATHLAB) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Dr. Lal PathLabs's Book Value per Share for the quarter that ended in Mar. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(18492.83	-	0)	/	83.2131
	=	222.23

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Dr. Lal PathLabs's Debt-to-Equity for the quarter that ended in Mar. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1439.11	+	1030.19)	/	18492.83
	=	0.13

Dr. Lal PathLabs Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Dr. Lal PathLabs's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Dr. Lal PathLabs (NSE:LALPATHLAB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Dr. Lal PathLabs Ltd (NSE:LALPATHLAB) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

539524:India

Address

12th Floor, Tower B, SAS Tower, Sector 38, Medicity, Gurugram, HR, IND, 122 001

Website

https://www.lalpathlabs.com

Dr. Lal PathLabs Ltd is a pathology lab based in India. It is involved in providing diagnostic services and other healthcare tests in the area of pathology and radiology. The company operates laboratories for carrying out pathological diagnostic services in various branches of biochemistry, hematology, histopathology, microbiology, electrophoresis, immunochemistry, immunology, virology, cytology, and other pathological and radiological investigations. Its diagnostic services assist to prevent, monitor and treat diseases and improving health conditions. The company has business operations in India and other countries, of which maximum revenue is generated within India.

Dr. Lal PathLabs (NSE:LALPATHLAB) Headlines

No Headlines